Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Early Development
    • Late Development
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us

Process R&D

Categories
BlogBook ChaptersCase StudiesPapersPatentsPresentationsThought LeadersWebinarsWhitepapers
Tags
Analytical Chemistry Analytical Science Artificial Intelligence (AI) Biocatalysis Catalysis CatSci Paper CatSci Patent Chemical Development Design of Experiments Digital Drug Development Experimental Design Green Chemistry Industry insights Innovation Machine Learning (ML) Material Science Medium Throughput Experimentation Oligonucleotides Principal Component Analysis Process R&D QbD Route Scouting and Selection Scale-up Scavenging Solvents Sustainability Technology transfer Work-up
Early Process Development and Scale-Up of Orally Active Apomorphine Drug Candidates

Org. Process Res. Dev. 2022

2022 By Antonio M. RudaEkaterina Y. MelikhovaJonathan D. MoseleyNadia Fleary-RobertsSiân M. ForsythSimon N. G. TylerSofia PapadouliVargini Thangavadivale, et al.
Application of the Polonovski Reaction: Scale-up of an Efficient and Environmentally Benign ...

Org. Process Res. Dev. 2022, 26, 5, 1398–1404

2022 By Antonio M. RudaSiân M. ForsythSofia PapadouliVargini Thangavadivale, et al.
Development of a Process to a 4-Arylated 2-Methylisoquinolin-1(2H)-one for the Treatment of ...

Org. Process Res. Dev. 2022, 26, 5, 1458–1469

2022 By Antonio M. RudaSiân M. Forsyth, et al.
Solvents In Scale-up Technical Piece – Part I

General points to consider on solvent selection for scale-up

2021 By CatSci team
The Next Decade of Drug Development 

Access the recordings of our 10-year anniversary symposium now. The event was centred on the future of medicines development and featured industry-leading speakers from AstraZeneca, Bristol Myers Squibb, DeepMatter, FogPharma, Merck, Novartis, R.I, Roche, Syngenta, and more.

2021
The Stability of Organometallics Technical Piece

Understanding their common decomposition pathways

2021 By CatSci team
Pharma Manufacturing: Pharma’s Shift Towards a Circular Economy

Our CCO, Dr Simon Tyler, argues that to achieve true sustainability, a more holistic approach to overall drug development is needed.

2021 By Simon N. G. Tyler
Fast UHPLC methods as a platform technology for expedited PR&D decision-making

CatSci's analytical team facilitated the development and deployment of an efficient and fast UHPLC method screening protocol.

2021 By Siân M. ForsythBeth Rees-HindleyDuncan ThompsonGareth Tutton
Solvents In Scale-up Technical Piece – Part II

Solvent Selection Considerations

2021 By CatSci team
Pharma’s Almanac: How Have Evolving Technologies Like Artificial Intelligence (AI) and...

The broader suite of computer-aided synthesis planning tools is increasingly catching up with chemists in its ability to establish the most suitable way of putting together a target active pharmaceutical ingredient.

2021 By Alan Steven
Chemical Development in Pharma 2: A CatSci Virtual Symposium 

Access the recordings of our second virtual symposium now. The event featured an impressive itinerary of three eminent speakers from industry, who delivered digestible 30-minute presentations, covering topics from high throughput experimentation in organic synthesis to separation technology and analytical science.

2021
Metal Scavenging Whitepaper

Development of a flow scavenging protocol

2021 By CatSci team
The Small Molecule Manufacturer: Solvents – Making the Green Choice

Dr Alan Steven explains why environmental sustainability and “big picture thinking” should be key considerations when selecting solvents for scale-up.

2021 By Alan Steven
Novel Bromination Process Slashes PMI

CatSci was tasked with designing a new bromination method for a key reaction intermediate. Use of bromine rendered the previous process unsuitable for a larger campaign and would require expensive and time-consuming alterations to the plant.

2021 By Guy BrenchleyDan RichardsJoanne B. SampsonMonica Trues-Suarez
Route Redesign to Eliminate Use of PhOCN

The route supplied by the client involved the use of phenyl cyanate for functionalising a heterocyclic intermediate with a nitrile group. Its ongoing use would require cyanide monitoring, a dedicated waste stream treatment step, and there were concerns over the sourcing of material of appropriate quality over the long term.

2021 By Marc HutchbyFil RotaGareth TuttonNadia Fleary-Roberts
Designing a Robust Scalable Catalytic Process

The client's Phase 1 process was struggling to deliver API in low kg qualities. In particular, Intermediate B was of variable quality, and residual metals were known to negatively affect the onward chemistry.

2020 By Vargini ThangavadivaleDan A. SmithSiân M. Forsyth
Solubility Data-Driven Workup Design & Crystallisation Development

CatSci was tasked with designing a new bromination method for a key reaction intermediate. Use of bromine rendered the previous process unsuitable for a larger campaign and would require expensive and time-consuming alterations to the plant.

2020 By Dan A. SmithAndrew RobertsAntonio M. RudaNadia Fleary-Roberts
Effective Route Scouting Allows Pilot Plant Slot To Be Met

CatSci was tasked with performing route-scouting, route selection and early-phase process development over a 6-month period to meet a pilot plant manufacturing slot.

2020 By Guy BrenchleyElise RochetteJoanne B. SampsonMarc Hutchby
Development of a Late-Stage Buchwald Amination

CatSci was tasked with the development of a regioselective Buchwald-Hartwig amination for the final bond forming step of an API. The inherited conditions were not robust with respect to reaction conversion leading to stability concerns.

2020 By Siân M. ForsythBeth Rees-HindleyJonathan D. MoseleyJoseph Renny
Chemical Development in Pharma: A CatSci Virtual Symposium

Access the recordings of our first virtual symposium now. The event featured an impressive itinerary of four eminent speakers spanning industry and academia, who delivered digestible 30-minute presentations, covering topics from green technologies to material science, such as crystallisation.

2020
Process for the preparation of bromodomain inhibitor

WO2020023438

2020 By Antonio M. Ruda, et al.
1 2 3 Next »

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • ESG Report 2022

What we do

  • What we do
    • Late Development
    • Early Development

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in drug development to accelerate the delivery of life-changing medicines to patients in need. 

© 2023 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.